Why COVID sufferers in the US can’t get ensitrelvir, the antiviral drug better than Paxlovid
For people suffering from a COVID-19 attack, the antiviral Paxlovid has been a godsend. The drug became the go-to antiviral treatment during the pandemic after the Food and Drug Administration granted it emergency use authorization in December 2021. Now there is a new antiviral drug superior to Paxlovid, but Americans can’t get it because it’s …
